VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42317575 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000200.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q42317575‏
024 ‎‡a 0000-0002-5980-7840‏ ‎‡2 orcid‏
024 ‎‡a 57198459548‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q42317575‏
100 0 ‎‡a Michael P Smith‏ ‎‡9 ast‏ ‎‡9 it‏ ‎‡9 sl‏ ‎‡9 es‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a মাইকেল পি স্মিথ‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a Michael P Smith‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Michael P Smith‏ ‎‡c onye nyocha‏ ‎‡9 ig‏
400 0 ‎‡a Michael P Smith‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF /AXL melanoma‏
670 ‎‡a Author's An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition‏
670 ‎‡a Author's Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma‏
670 ‎‡a Author's Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.‏
670 ‎‡a Author's Differentiation of THP1 Cells into Macrophages for Transwell Co-culture Assay with Melanoma Cells.‏
670 ‎‡a Author's Discovery of a Gatekeeper Residue in the C-Terminal Tail of the Extracellular Signal-Regulated Protein Kinase 5 (ERK5)‏
670 ‎‡a Author's Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma‏
670 ‎‡a Author's Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish‏
670 ‎‡a Author's Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.‏
670 ‎‡a Author's Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy‏
670 ‎‡a Author's MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide‏
670 ‎‡a Author's Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance.‏
670 ‎‡a Author's Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival‏
670 ‎‡a Author's Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs‏
670 ‎‡a Author's Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure‏
670 ‎‡a Author's Targeting MITF in the tolerance-phase‏
670 ‎‡a Author's The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα‏
909 ‎‡a (scopus) 57198459548‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000259807840‏ ‎‡9 1‏
919 ‎‡a pax3brn2rheostatcontrolsthedynamicsofbrafmediatedmitfregulationinmitfaxlmelanoma‏ ‎‡A A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF /AXL melanoma‏ ‎‡9 1‏
919 ‎‡a immunemicroenvironmentconfersresistancetomapkpathwayinhibitorsthroughmacrophagederivedtnfα‏ ‎‡A The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα‏ ‎‡9 1‏
919 ‎‡a targetingmitfinthetolerancephase‏ ‎‡A Targeting MITF in the tolerance-phase‏ ‎‡9 1‏
919 ‎‡a targetingendothelinreceptorsignallingovercomesheterogeneitydriventherapyfailure‏ ‎‡A Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure‏ ‎‡9 1‏
919 ‎‡a reciprocalprimingbetweenreceptortyrosinekinasesatrecyclingendosomesorchestratescellularsignallingoutputs‏ ‎‡A Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs‏ ‎‡9 1‏
919 ‎‡a osteoblastscontributetoaprotectivenichethatsupportsmelanomacellproliferationandsurvival‏ ‎‡A Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival‏ ‎‡9 1‏
919 ‎‡a molecularpathwaysmaintainingmapkinhibitorsensitivitybytargetingnonmutationaltolerance‏ ‎‡A Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance.‏ ‎‡9 1‏
919 ‎‡a mgmtexpressionpredictsparpmediatedresistancetotemozolomide‏ ‎‡A MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide‏ ‎‡9 1‏
919 ‎‡a inhibitingdriversofnonmutationaldrugtoleranceisasalvagestrategyfortargetedmelanomatherapy‏ ‎‡A Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy‏ ‎‡9 1‏
919 ‎‡a glucoseavailabilitycontrolsatf4mediatedmitfsuppressiontodrivemelanomacellgrowth‏ ‎‡A Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.‏ ‎‡9 1‏
919 ‎‡a enhancedfattyacidscavengingandglycerophospholipidmetabolismaccompanymelanocyteneoplasiaprogressioninzebrafish‏ ‎‡A Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish‏ ‎‡9 1‏
919 ‎‡a effectofsmurf2targetingonsusceptibilitytomekinhibitorsinmelanoma‏ ‎‡A Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma‏ ‎‡9 1‏
919 ‎‡a discoveryofagatekeeperresidueinthe100terminaltailoftheextracellularsignalregulatedproteinkinase5erk5‏ ‎‡A Discovery of a Gatekeeper Residue in the C-Terminal Tail of the Extracellular Signal-Regulated Protein Kinase 5 (ERK5)‏ ‎‡9 1‏
919 ‎‡a differentiationofthp1cellsintomacrophagesfortranswellcocultureassaywithmelanomacells‏ ‎‡A Differentiation of THP1 Cells into Macrophages for Transwell Co-culture Assay with Melanoma Cells.‏ ‎‡9 1‏
919 ‎‡a collagenabundancecontrolsmelanomaphenotypesthroughlineagespecificmicroenvironmentsensing‏ ‎‡A Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.‏ ‎‡9 1‏
919 ‎‡a biomarkeraccessibleandchemicallyaddressablemechanisticsubtypesofbrafmelanoma‏ ‎‡A Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma‏ ‎‡9 1‏
919 ‎‡a adaptivesignalingnetworkinmelanomainflammatorynichesconferstolerancetomapksignalinginhibition‏ ‎‡A An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 83134626
996 ‎‡2 PLWABN|9810532230005606
996 ‎‡2 LC|n 79091581
996 ‎‡2 BNE|XX5801727
996 ‎‡2 BIBSYS|7002496
996 ‎‡2 DBC|87097969700659
996 ‎‡2 DNB|128641606
996 ‎‡2 RERO|A006503884
996 ‎‡2 J9U|987007390647505171
996 ‎‡2 DNB|1195238495
996 ‎‡2 DNB|140139532
996 ‎‡2 CAOONL|ncf10456280
996 ‎‡2 B2Q|0000687974
996 ‎‡2 ISNI|000000002567802X
996 ‎‡2 N6I|vtls002825999
996 ‎‡2 ISNI|0000000440050926
996 ‎‡2 CAOONL|ncf11340364
996 ‎‡2 NKC|stk2007428554
996 ‎‡2 CAOONL|ncf12129943
996 ‎‡2 SUDOC|035735074
996 ‎‡2 ISNI|0000000498810166
996 ‎‡2 NUKAT|n 2022131468
996 ‎‡2 LC|n 85325206
996 ‎‡2 BNF|13606994
996 ‎‡2 LC|no2016122970
996 ‎‡2 DNB|122340644X
996 ‎‡2 ISNI|000000003842087X
996 ‎‡2 ICCU|BVEV185739
996 ‎‡2 LC|n 2001001297
996 ‎‡2 J9U|987007594768505171
996 ‎‡2 BIBSYS|90746496
996 ‎‡2 ISNI|0000000054822596
996 ‎‡2 ISNI|0000000034511918
996 ‎‡2 BNC|981058517127706706
996 ‎‡2 NUKAT|n 2007154236
996 ‎‡2 BIBSYS|7026241
996 ‎‡2 LC|no2023131374
996 ‎‡2 J9U|987007392051805171
996 ‎‡2 LC|no2017152866
996 ‎‡2 J9U|987007421735105171
996 ‎‡2 DNB|1158007965
996 ‎‡2 LC|no2024021096
996 ‎‡2 ISNI|0000000083174428
996 ‎‡2 NUKAT|n 2009106422
996 ‎‡2 J9U|987007447883305171
996 ‎‡2 NTA|072391308
996 ‎‡2 ISNI|0000000035940319
996 ‎‡2 LC|no 94006876
996 ‎‡2 CAOONL|ncf11195824
996 ‎‡2 LC|no 00079364
996 ‎‡2 ISNI|0000000454190655
996 ‎‡2 DNB|117436488
996 ‎‡2 ISNI|0000000109319251
996 ‎‡2 ISNI|0000000410114554
996 ‎‡2 NKC|xx0030500
996 ‎‡2 PLWABN|9810680694205606
996 ‎‡2 NTA|072574062
996 ‎‡2 NLA|000035507367
996 ‎‡2 BIBSYS|7065958
996 ‎‡2 RERO|A003827595
996 ‎‡2 DNB|1069884448
996 ‎‡2 LC|no2002060232
996 ‎‡2 ISNI|0000000025418658
996 ‎‡2 NII|DA01355522
996 ‎‡2 ISNI|0000000114664869
996 ‎‡2 NUKAT|n 99003985
996 ‎‡2 ERRR|12172571
996 ‎‡2 BNF|12308345
996 ‎‡2 J9U|987007333036405171
996 ‎‡2 BIBSYS|90068093
996 ‎‡2 NLA|000035304555
996 ‎‡2 LC|nb 90025723
996 ‎‡2 LC|nb 90025722
996 ‎‡2 LC|nb 90025724
996 ‎‡2 SUDOC|146655303
996 ‎‡2 ISNI|0000000047789134
996 ‎‡2 BNCHL|10000000000000000113813
996 ‎‡2 ISNI|0000000073252584
996 ‎‡2 ISNI|0000000073925208
996 ‎‡2 J9U|987007277231405171
996 ‎‡2 NUKAT|n 2007132321
996 ‎‡2 BNE|XX5321397
996 ‎‡2 LC|no2017078719
996 ‎‡2 LC|nb2021014839
996 ‎‡2 NII|DA18387986
996 ‎‡2 ISNI|0000000068377972
996 ‎‡2 ISNI|0000000114525201
996 ‎‡2 NUKAT|n 2012063245
996 ‎‡2 NTA|328215511
996 ‎‡2 SELIBR|264945
996 ‎‡2 J9U|987007446427105171
996 ‎‡2 LC|n 2006077324
996 ‎‡2 LC|n 80006341
996 ‎‡2 DNB|1061649792
996 ‎‡2 RERO|A020127894
996 ‎‡2 ISNI|0000000435041785
996 ‎‡2 RERO|A026776829
996 ‎‡2 ISNI|000000037987954X
996 ‎‡2 LC|no2009175167
996 ‎‡2 DNB|1325549118
996 ‎‡2 J9U|987007452345105171
996 ‎‡2 ISNI|0000000084578408
996 ‎‡2 J9U|987007335944705171
996 ‎‡2 LC|no2011020344
996 ‎‡2 BNC|981058611425406706
996 ‎‡2 BNF|16686131
996 ‎‡2 LC|no2017138130
996 ‎‡2 BNF|14580551
996 ‎‡2 LC|n 2018188473
996 ‎‡2 LC|no2012030262
996 ‎‡2 ISNI|0000000088257564
996 ‎‡2 J9U|987007452334105171
996 ‎‡2 DNB|173320309
996 ‎‡2 BIBSYS|90383626
996 ‎‡2 NUKAT|n 2019212865
996 ‎‡2 J9U|987007439619705171
996 ‎‡2 DNB|133149060X
996 ‎‡2 ISNI|0000000037414099
996 ‎‡2 BNF|15089124
996 ‎‡2 J9U|987007407224905171
996 ‎‡2 DNB|1191516571
996 ‎‡2 LC|no2017123889
996 ‎‡2 LC|no2003080405
996 ‎‡2 BIBSYS|3095086
996 ‎‡2 J9U|987007445058305171
996 ‎‡2 ISNI|0000000039063448
996 ‎‡2 LC|no2023007759
996 ‎‡2 RERO|A006367321
996 ‎‡2 SUDOC|075434326
996 ‎‡2 NUKAT|n 96103795
996 ‎‡2 LC|no 99036317
996 ‎‡2 LC|no 98121355
996 ‎‡2 BNC|981058515029906706
996 ‎‡2 J9U|987007268188805171
996 ‎‡2 ISNI|0000000039334009
996 ‎‡2 LC|no2009054422
996 ‎‡2 RERO|A000150945
996 ‎‡2 PLWABN|9810613300105606
996 ‎‡2 SUDOC|121114546
996 ‎‡2 SUDOC|029811120
996 ‎‡2 NUKAT|n 2017067373
996 ‎‡2 CAOONL|ncf11633758
996 ‎‡2 LNB|LNC10-000045299
996 ‎‡2 LC|n 94091133
996 ‎‡2 CAOONL|ncf10993718
996 ‎‡2 ISNI|0000000455420037
996 ‎‡2 LC|nr2004034308
996 ‎‡2 LC|no 98004579
996 ‎‡2 SELIBR|92820
996 ‎‡2 NTA|357208943
996 ‎‡2 NUKAT|n 2015136533
996 ‎‡2 LC|nb2004001040
996 ‎‡2 BIBSYS|1470399606122
996 ‎‡2 NII|DA05320439
996 ‎‡2 DNB|1129698157
996 ‎‡2 ISNI|0000000085305364
996 ‎‡2 LC|no2003099713
996 ‎‡2 NUKAT|n 2013183124
996 ‎‡2 ISNI|0000000037108489
996 ‎‡2 LC|nb2012016854
996 ‎‡2 LC|nb2005019949
996 ‎‡2 LC|no 94028021
996 ‎‡2 LC|nb2011015867
996 ‎‡2 BIBSYS|90137039
996 ‎‡2 J9U|987007281340205171
996 ‎‡2 LC|nb 99054186
996 ‎‡2 BIBSYS|7017177
996 ‎‡2 LC|no2009067554
996 ‎‡2 ISNI|0000000050690901
996 ‎‡2 LC|n 80104929
996 ‎‡2 LC|n 2012187503
996 ‎‡2 ISNI|0000000043387672
996 ‎‡2 NUKAT|n 2016012510
996 ‎‡2 LC|no 98076112
996 ‎‡2 J9U|987007437615605171
996 ‎‡2 NKC|xx0192765
996 ‎‡2 NKC|jn20040107006
996 ‎‡2 CAOONL|ncf10691703
996 ‎‡2 LC|n 84218293
996 ‎‡2 SUDOC|19562825X
996 ‎‡2 LC|nb2013011763
996 ‎‡2 LC|no2016112964
996 ‎‡2 BIBSYS|1698994099831
996 ‎‡2 LC|no2019050048
996 ‎‡2 ISNI|0000000117541901
996 ‎‡2 JPG|500006663
996 ‎‡2 LC|n 81029046
996 ‎‡2 LC|no2010151002
996 ‎‡2 LC|no2023124607
996 ‎‡2 ISNI|0000000428300363
996 ‎‡2 LC|n 89612560
996 ‎‡2 LC|no2018125265
996 ‎‡2 J9U|987007439762105171
996 ‎‡2 ISNI|0000000121024261
996 ‎‡2 LC|n 80118183
996 ‎‡2 NSK|000386690
996 ‎‡2 ISNI|0000000114901836
996 ‎‡2 BIBSYS|2005270
996 ‎‡2 ISNI|0000000072780326
996 ‎‡2 BNF|12639775
996 ‎‡2 NKC|jo20191021992
996 ‎‡2 BNF|15726929
996 ‎‡2 LC|n 00020697
996 ‎‡2 NUKAT|n 2006115646
996 ‎‡2 LC|n 00020695
996 ‎‡2 LC|n 00020694
996 ‎‡2 LC|n 85069186
996 ‎‡2 DNB|1249853494
996 ‎‡2 ISNI|0000000078991036
996 ‎‡2 RERO|A018709155
996 ‎‡2 BNF|15117499
996 ‎‡2 J9U|987007268188905171
996 ‎‡2 SUDOC|14023697X
996 ‎‡2 CAOONL|ncf11368078
996 ‎‡2 J9U|987007386780305171
996 ‎‡2 NKC|xx0267435
996 ‎‡2 LC|nb2001036607
996 ‎‡2 ISNI|0000000083680478
996 ‎‡2 LC|nb2005002841
996 ‎‡2 BNC|981058617252306706
996 ‎‡2 ISNI|0000000454584179
996 ‎‡2 NUKAT|n 96002801
996 ‎‡2 CAOONL|ncf11912479
996 ‎‡2 N6I|vtls001104230
996 ‎‡2 NTA|146827384
996 ‎‡2 NII|DA18456309
996 ‎‡2 SUDOC|077497651
996 ‎‡2 VLACC|000002220
996 ‎‡2 J9U|987007437765605171
996 ‎‡2 LC|n 2001112795
996 ‎‡2 LC|nb2002087118
996 ‎‡2 BIBSYS|98064207
996 ‎‡2 NUKAT|n 2012066708
996 ‎‡2 ISNI|0000000356116128
996 ‎‡2 LC|n 97021916
996 ‎‡2 ISNI|0000000043312339
996 ‎‡2 SUDOC|06074233X
996 ‎‡2 NKC|mub2011638457
996 ‎‡2 NTA|067970737
996 ‎‡2 BLBNB|000186209
996 ‎‡2 LC|nb2016013124
996 ‎‡2 ISNI|0000000452872900
996 ‎‡2 SIMACOB|255429219
996 ‎‡2 BNE|XX5093910
996 ‎‡2 ISNI|0000000371156881
996 ‎‡2 BLBNB|001483520
996 ‎‡2 J9U|987007350754605171
996 ‎‡2 ISNI|0000000045988172
996 ‎‡2 NUKAT|n 2016243367
996 ‎‡2 LC|no2007054413
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏